Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis

被引:95
|
作者
Gnanasekar, Munirathinam [1 ]
Thirugnanam, Sivasakthivel [1 ]
Ramaswamy, Kalyanasundaram [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Biomed Sci, Rockford, IL 61107 USA
关键词
HMGB1; LNCaP; prostate cancer; ShRNA; GLYCATION END-PRODUCTS; SMALL INTERFERING RNA; MAMMALIAN-CELLS; HIGH-MOBILITY-GROUP-BOX-1; HMGB1; CHROMATIN PROTEIN; AMPHOTERIN; INFLAMMATION; RAGE; RECEPTOR; THERAPY;
D O I
10.3892/ijo_00000166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box protein I (HMGB1), transcriptional activity regulatory protein is associated with most cancers including prostate cancer. To investigate the effects of down-regulation of HMGB1 expression, we have transfected LNCaP cells with four short hairpin RNA (shRNA) targeting HMGB I plasmid vectors. Transfection with the four shRNAs efficiently and specifically reduced the HMGB1 expression in LNCaP cells. The gene silencing effects on HMGB1 expression were subsequently confirmed by RT-PCR and immunoblotting analyses. Down-regulation of HMGB1 expression resulted in the inhibition of cell growth in LNCaP prostate cancer cells and the decreased cell number was due to transfected cells undergoing apoptosis via caspase-3-dependent pathways. These findings suggest that HMGB I is critical for the survival of prostate cancer cells and targeted knockdown of HMGB1 mRNA can be used as a strategy to kill prostate cancer cells. Our findings may have some potential therapeutic relevance for treating prostate cancer.
引用
收藏
页码:425 / 431
页数:7
相关论文
共 50 条
  • [1] Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome
    Kam, Angel Y. F.
    Piryani, Sadhna O.
    McCall, Chad M.
    Park, Hee Su
    Rizzieri, David A.
    Phuong L Doan
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 4155 - 4167
  • [2] High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
    Vijayakumar, Eyaldeva C.
    Bhatt, Lokesh Kumar
    Prabhavalkar, Kedar S.
    CURRENT DRUG TARGETS, 2019, 20 (14) : 1474 - 1485
  • [3] The role of high-mobility group box-1 (HMGB1) in the pathogenesis of asthma
    Shim, E. -J.
    Chun, E.
    Lee, H. -S.
    Bang, B. -R.
    Kim, T. -W.
    Cho, S. -H.
    Min, K. -U.
    Park, H. -W.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06): : 958 - 965
  • [4] High Mobility Group box-1 (HMGB1) Protein As a Biomarker for Acute Cholecystitis
    Amini, Mahmoud
    Pakdaman, Abdolali
    Shapoori, Shima
    Mosayebi, Ghasem
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 7 (02): : 204 - 209
  • [5] Interaction of High Mobility Group Box-1 (HMGB1) with α-synuclein and its aggregation
    Ko, Eun Ae
    Min, Hyun Jin
    Shin, Jeon-Soo
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [6] The role of high mobility group box 1 (HMGB1) in prostate carcinogenesis
    Patel, Purvi
    Zheng, Michelle
    Bosland, Maarten C.
    Kajdacsy-Balla, Andre
    Munirathinam, Gnanasekar
    CANCER RESEARCH, 2012, 72
  • [7] The role of high mobility group box-1 protein (HMGB1) in the microenvironment of non-small cell lung cancer
    Habu, Tomohiro
    Date, Keiichi
    Suzawa, Ken
    Yoshikawa, Mao
    Ohki, Masayoshi
    Iwata, Kazuma
    Matsuda, Naoki
    Thu, Yin Min
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Toyooka, Shinichi
    CANCER RESEARCH, 2023, 83 (07)
  • [8] High Mobility Group Box-1 (HMGB1; Amphoterin) Is Required for Zebrafish Brain Development
    Zhao, Xiang
    Kuja-Panula, Juha
    Rouhiainen, Ari
    Chen, Yu-chia
    Panula, Pertti
    Rauvala, Heikki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (26) : 23200 - 23213
  • [9] High Mobility Group Box 1 (HMGB1) expression in gastric adenocarcinomas
    Suren, Dinc
    Gokay, Ahmet Arda
    Sayiner, Alper
    JOURNAL OF BUON, 2018, 23 (02): : 422 - 427
  • [10] Expression of high-mobility group box-1 (HMGB1) in the basilar artery after experimental subarachnoid hemorrhage
    Zhao, Xu Dong
    Mao, Hai Yan
    Lv, Jing
    Lu, Xiao Jie
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 27 : 161 - 165